Pharma & Healthcare
Whether it's the restructuring of the hospital sector, the impact of AI on healthcare, the resilience of IT systems, or a changing age structure of the population: the healthcare industry is constantly experiencing changes and challenges. The dynamic nature of such developments is coupled with various regulatory requirements. We advise companies from all areas of the healthcare and pharmaceutical sector on industry-specific issues in the areas of antitrust law, public procurement law and foreign trade law, such as purchasing cooperations in the hospital sector, the procurement of software (as a service) or the export control of medical products.
Contact: Florian Wolf, Christopher Wolters, Marie-Luise Heuer
References
Advising BPI on public procurement law issues regarding the consideration of the production location when awarding discount contracts for off-patent drugs with critical active ingredients by the health insurance funds
Advising various IT companies regarding procurement procedures for digital solutions in the healthcare sector (e.g. Recare, Kumi Health and Thieme DokuForm)
Advising and representing multinational health care company Teva on direct investment law issues regarding the FDI filing of its licensing collaboration with MODAG
Advising a leading U.S. provider of medical and pharmaceutical products in the cannabis tender of the Federal Institute for Drugs and Medical Devices
Advising on merger control law (e.g. sale of medpex to DocMorris, sale of care services by Vitruvian Partners, acquisition of a medical practice portfolio and a dental clinic by Summit Partners, acquisition of a veterinary clinic by Swedish PE investor IVC Evidensia)
Advising regularly on antitrust distribution issues (e.g. Essity/BSN)
Advising a Blue Chip medical company on international trade law matters
Advising Eckert & Ziegler AG on international trade law matters
Advising Advanced MedTech on EU sanctions law matters
Advising a European pharmaceutical company on subsidy and public procurement law
The BLOMSTEIN team has supported us comprehensively on all aspects of the Krankenhauszukunftsgesetz and has accompanied us in several tenders. The legal advice is excellent and, what I appreciate particularly as an entrepreneur, we have always considered the team a pragmatic sparring partner in every tender.
Excellent Customs and Export Control practice, with great and very practical responsiveness to the point. Great team.